Study Groups with Peter Culpepper

GLG clusters experts with similar professional backgrounds (based on industry expertise, experience level, job function, geography and others) into ‘Study Groups’.

Study Group Name No. Members
Biopharmaceutical Financial Statement Analysts 30
Biopharmaceuticals Manufacturers (US) 43
Chief Financial Officers 2136
Current or Former Chief Financial Officers in the Pharmaceuticals & Biotechnology Manufacturing and Research Industry 109
Financial Statement Analysts - Leaders, Scholars, and Educators 329
Sarbanes-Oxley Accounting Experts 19
Sarbanes-Oxley Specialists 303
US GAAP Healthcare Specialists 332

Page : 11 to 8 of 8

Leading institutions connect with members of the Accounting & Financial Analysis councils through GLG

Get Intelligently Connected
with the world's leading experts

GLG's 850+ Clients Include:

More than 70% of the world's leading
mutual funds
15 of the leading 20
global banks
9 of the leading 10
global private equity firms
5 of the leading 10
AmLaw firms
Fortune 500® Companies
in nearly every industry sector, including pharmaceuticals, insurance, chemicals, energy and computer software